224 related articles for article (PubMed ID: 1729931)
1. Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry.
Larach MG; Landis JR; Bunn JS; Diaz M
Anesthesiology; 1992 Jan; 76(1):16-27. PubMed ID: 1729931
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.
Allen GC; Larach MG; Kunselman AR
Anesthesiology; 1998 Mar; 88(3):579-88. PubMed ID: 9523799
[TBL] [Abstract][Full Text] [Related]
3. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
4. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
[TBL] [Abstract][Full Text] [Related]
5. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
Ginz HF; Girard T; Censier K; Urwyler A
Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
[TBL] [Abstract][Full Text] [Related]
6. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Sato N; Brum JM; Mitsumoto H; DeBoer GE
Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
[TBL] [Abstract][Full Text] [Related]
7. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
Wappler F; Anetseder M; Baur CP; Censier K; Doetsch S; Felleiter P; Fiege M; Fricker R; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Hopkins PM; Klingler W; Lehmann-Horn F; Nivoche Y; Tegazzin V; Tzanova I; Urwyler A; Weisshorn R; Schulte am Esch J
Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of the contracture test for diagnosing malignant hyperthermia in a Brazilian population sample: a retrospective observational study.
de Mello JM; Andrade PV; Santos JM; Oliveira ASB; Vainzof M; do Amaral JLG; Almeida da Silva HC
Braz J Anesthesiol; 2023; 73(2):145-152. PubMed ID: 35835312
[TBL] [Abstract][Full Text] [Related]
9. [Tests of contracture and sensitivity to malignant hyperthermia in 27 patients].
Krivosic-Horber R; Adnet P; Krivosic I; Theunynck D; Guévart E; Adamantidis M
Ann Fr Anesth Reanim; 1988; 7(2):132-8. PubMed ID: 3364812
[TBL] [Abstract][Full Text] [Related]
10. Malignant hyperthermia in humans--standardization of contracture testing protocol.
Melton AT; Martucci RW; Kien ND; Gronert GA
Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
[TBL] [Abstract][Full Text] [Related]
11. A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
Olgin J; Rosenberg H; Allen G; Seestedt R; Chance B
Anesth Analg; 1991 Jan; 72(1):36-47. PubMed ID: 1984374
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
[TBL] [Abstract][Full Text] [Related]
13. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
[TBL] [Abstract][Full Text] [Related]
14. [Contracture test with ionophore A 23187 for the diagnosis of malignant hyperthermia].
Moeller R; Kozak-Reiss G; Gascard JP; Laxenaire MC
Ann Fr Anesth Reanim; 1986; 5(2):177-81. PubMed ID: 3089080
[TBL] [Abstract][Full Text] [Related]
15. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
Iaizzo PA; Wedel DJ; Gallagher WJ
Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
[TBL] [Abstract][Full Text] [Related]
16. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.
Allen GC; Fletcher JE; Huggins FJ; Conti PA; Rosenberg H
Anesthesiology; 1990 Jan; 72(1):71-6. PubMed ID: 2297135
[TBL] [Abstract][Full Text] [Related]
17. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.
Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F
Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Hopkins PM; Ellis FR; Halsall PJ
Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
[TBL] [Abstract][Full Text] [Related]
20. [Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil].
Almeida da Silva HC; Ferreira G; Rodrigues G; Santos JMD; Andrade PV; Hortense A; Vaz Perez M; Amaral JLGD
Braz J Anesthesiol; 2019; 69(2):152-159. PubMed ID: 30935497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
